agilon health (AGL) financial statements
agilon health reported revenue of $5.9B in fiscal 2025, up 39.8% a year over 6 years.
Net income was -$391M and the operating margin -7.8%, against -13.4% in 2019.
Free cash flow was -$119M.
The diluted share count rose 40% over the period (dilution).
Revenue and free cash flow
Fiscal years, $ billions.
Income statement
Fiscal years, from agilon health's 10-K filings with the SEC.
| Fiscal year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | $794M | $1.2B | $1.5B | $2.4B | $4.3B | $6.1B | $5.9B |
| Selling, general and admin | $123M | $137M | $428M | $208M | $286M | $269M | $239M |
| Operating income | -$107M | -$57M | -$372M | -$105M | -$232M | -$292M | -$463M |
| Interest expense | $9M | $8M | $6M | $4M | $7M | $6M | $7M |
| Pre-tax income | -$115M | -$62M | -$383M | -$91M | -$194M | -$249M | -$404M |
| Income tax | -$232,000 | $865,000 | $886,000 | $2M | $791,000 | $1M | $1M |
| Net income | -$283M | -$60M | -$406M | -$107M | -$263M | -$260M | -$391M |
| Diluted shares | 12M | 13M | 15M | 16M | 16M | 16M | 17M |
| Operating margin | -13.4% | -4.7% | -24.5% | -4.4% | -5.4% | -4.8% | -7.8% |
| Net margin | -35.6% | -4.9% | -26.7% | -4.5% | -6.1% | -4.3% | -6.6% |
Balance sheet
Fiscal years, from agilon health's 10-K filings with the SEC.
| Fiscal year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Cash and short-term investments | $139M | $107M | $1.0B | $877M | $108M | $188M | $174M |
| Receivables | — | $145M | $293M | $492M | $942M | $1.0B | $674M |
| Total current assets | — | $294M | $1.4B | $1.5B | $1.5B | $1.5B | $1.1B |
| Property, plant and equipment | — | $6M | $9M | $20M | $28M | $28M | $25M |
| Goodwill | — | $42M | $42M | $3M | $24M | $24M | $0 |
| Total assets | — | $446M | $1.6B | $1.7B | $1.7B | $1.7B | $1.3B |
| Total current liabilities | — | $267M | $357M | $535M | $977M | $1.2B | $1.1B |
| Long-term debt | — | $65M | $43M | $38M | $32M | $35M | $16M |
| Total liabilities | — | $422M | $495M | $657M | $1.1B | $1.3B | $1.1B |
| Shareholders' equity | -$232M | -$285M | $1.1B | $1.0B | $662M | $471M | $127M |
| Net debt | -$139M | -$39M | -$992M | -$422M | -$69M | -$153M | -$139M |
Cash flow
Fiscal years, from agilon health's 10-K filings with the SEC.
| Fiscal year | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | -$104M | -$53M | -$148M | -$131M | -$156M | -$58M | -$106M |
| Capital spending | $3M | $2M | $7M | $15M | $16M | $13M | $13M |
| Free cash flow | -$107M | -$55M | -$155M | -$146M | -$172M | -$71M | -$119M |
| Stock-based compensation | $5M | $7M | $292M | $28M | $69M | $51M | $49M |
| Share buybacks (net) | — | -$7M | — | — | -$200M | — | — |
| Net borrowing | -$4M | -$3M | -$20M | -$5M | -$5M | -$4M | $0 |
| Free cash flow margin | -13.4% | -4.5% | -10.2% | -6.1% | -4.0% | -1.2% | -2.0% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for AGL.
Open AGL in InvestinglyQuestions
What was agilon health's revenue in 2025?
$5.9B in fiscal 2025, from its 10-K filing.
How much free cash flow does agilon health generate?
-$119M in fiscal 2025 (operating cash flow minus capital spending).
From agilon health's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.